NCT06773988Recruiting
Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy
Source: ClinicalTrials.gov · Last updated 14 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to verify whether full video home polysomnography (sleep study) with nocturnal transcutaneous CO2 monitoring is feasible in the follow-up of non-invasive ventilation (NIV) in patients with Duchenne muscular dystrophy. The researchers would like to investigate whether they could perform sufficient measurements in the home situation and see if correct decision for further treatment could be made. Furthermore, the researchers will make an analysis on the minimal requirements of measurements to make a correct decision for the treatment of these patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 17 (estimated)
- First submitted
- 4 Dec 2024
- Start date
- 6 Dec 2024
- Primary completion date
- 31 Oct 2027
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Diseases
- Duchenne muscular dystrophy
- NCT number
- NCT06773988
What you commit to
- Study type: Observational
- Planned participants: 17
- From 6 Dec 2024 to the primary completion date, 31 Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- /
Who the study is looking for
- Patients with DMD \> 18 years using NIV
- Signing the written informed consent
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitaire Ziekenhuizen KU Leuven Coordinator of this site? Confirm its status | Leuven | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.